ALLIANCE PHARMA LS-,01ALLIANCE PHARMA LS-,01ALLIANCE PHARMA LS-,01

ALLIANCE PHARMA LS-,01

No trades
See on Supercharts
Market capitalization
‪229.60 M‬EUR
‪1.06 M‬EUR
‪189.18 M‬EUR
‪401.11 M‬
Beta (1Y)
1.69

About ALLIANCE PHARMA LS-,01

CEO
Peter Jonathan Butterfield
Headquarters
Chippenham
Employees (FY)
285
Founded
2001
ISIN
GB0031030819
FIGI
BBG000QY2T55
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ALLIANCE PHARMA LS-,01 stocks are traded under the ticker DVL.
ALLIANCE PHARMA LS-,01 is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ALLIANCE PHARMA LS-,01 has a max estimate of 1.170 EUR and a min estimate of 0.492 EUR.
DVL earnings for the last quarter are 0.03 EUR whereas the estimation was 0.03 EUR which accounts for 14.40% surprise. Estimated earnings for the next quarter are 0.02 EUR. See more details about ALLIANCE PHARMA LS-,01 earnings.
ALLIANCE PHARMA LS-,01 revenue for the last quarter amounts to ‪91.47 M‬ EUR despite the estimated figure of ‪94.77 M‬ EUR. In the next quarter revenue is expected to reach ‪95.89 M‬ EUR.
Yes, you can track ALLIANCE PHARMA LS-,01 financials in yearly and quarterly reports right on TradingView.
ALLIANCE PHARMA LS-,01 dividend yield was 3.35% in 2022, and payout ratio reached ‪1.04 K‬%. The year before the numbers were 1.55% and 123.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIANCE PHARMA LS-,01 stock right from TradingView charts — choose your broker and connect to your account.
DVL reached its all-time high on May 30, 2001 with the price of 9.900 EUR, and its all-time low was 0.356 EUR and was reached on Nov 14, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 285.00 employees. See our rating of the largest employees — is ALLIANCE PHARMA LS-,01 on this list?
We've gathered analysts' opinions on ALLIANCE PHARMA LS-,01 future price: according to them, DVL price has a max estimate of 1.17 EUR and a min estimate of 0.49 EUR. Read a more detailed ALLIANCE PHARMA LS-,01 forecast: see what analysts think of ALLIANCE PHARMA LS-,01 and suggest that you do with its stocks.